MSOs Set for $1B in Tax Refunds, $2B Annual Savings From Rescheduling

The Tax Math Behind the Windfall

The $1 billion refund figure represents three years of disallowed deductions that MSOs can now amend and reclaim once rescheduling takes effect. Section 280E has forced cannabis operators to pay federal income tax on gross profit rather than net income, inflating effective tax rates to 70% or higher in some cases. Rescheduling to Schedule III removes cannabis from the statute's scope, allowing standard business deductions for rent, payroll, marketing, and operational costs.

Annual savings? North of $2 billion across the industry's top 15 MSOs, based on 2025 revenue and margin data. Companies with EBITDA margins in the 20-30% range will see the steepest profitability gains, as previously non-deductible expenses drop straight to the bottom line.

Refunds begin flowing 90-180 days after the DEA finalizes its rescheduling rule, currently under Office of Management and Budget review. Operators will file amended returns for tax years still open under the IRS statute of limitations—typically the prior three years.

Which MSOs Benefit Most

Vertically integrated operators with high non-COGS expenses stand to gain the most from 280E repeal. Companies spending heavily on retail buildout, brand marketing, and multi-state compliance infrastructure have carried the heaviest 280E burden. Curaleaf, Trulieve, Green Thumb Industries, and Cresco Labs—the four largest MSOs by revenue—collectively paid an estimated $600 million in excess federal tax over the past three years that becomes reclaimable.

Single-state operators and smaller MSOs will see proportionally smaller refunds but identical margin expansion on a percentage basis. The tax relief doesn't favor scale; it favors expense intensity. A dispensary chain with 15% EBITDA margins and high marketing spend may see bigger margin improvement than a cultivation-heavy operator already running 35% EBITDA.

Retroactive Relief Mechanics

MSOs can file IRS Form 1120X to amend federal returns for any tax year still within the three-year statute of limitations. For rescheduling finalized in late 2026, that opens 2023, 2024, and 2025 returns for amendment. Companies will recalculate taxable income using standard Schedule C or corporate deductions, then claim refunds for overpaid tax plus statutory interest.

The IRS hasn't issued guidance specific to cannabis rescheduling, but tax attorneys expect the agency to apply existing amended-return procedures. Processing times for amended corporate returns historically run six to nine months. First refund checks likely arrive in Q2 2027 if rescheduling lands by year-end 2026.

One complication: MSOs that took large state-level tax deductions for federal 280E disallowances may face state tax adjustments when they reclaim federal refunds. California, for instance, allows a deduction for the federal 280E penalty—eliminating that penalty could trigger state tax bills that partially offset federal refunds.

Annual Savings and Margin Expansion

The $2 billion annual savings figure assumes the top 15 MSOs maintain current revenue levels and cost structures post-rescheduling. In practice, margin expansion will compound as operators reinvest tax savings into growth, driving revenue higher. A company saving $50 million annually in federal tax can plow that capital into new dispensaries, acquisitions, or debt paydown—all of which improve long-term profitability.

Rescheduling doesn't just fix the tax code; it fixes the capital structure problem that's kept institutional investors on the sidelines.

Analysts at Viridian Capital Advisors estimate that eliminating 280E will boost average MSO EBITDA margins by 8-12 percentage points. For a company running 25% EBITDA today, that means a jump to 33-37%. Cannabis operators would match alcohol distributors and tobacco companies on a margin basis.

State Tax Implications

Not all states will automatically conform to federal rescheduling for tax purposes. California, Massachusetts, and Illinois tie their cannabis tax codes to federal Schedule I status in ways that may require legislative fixes. If a state's tax law explicitly references Schedule I or 280E, rescheduling could create ambiguity about whether state-level deductions still apply.

Colorado and Washington, by contrast, have decoupled state cannabis taxes from federal scheduling entirely. Operators in those states will see full federal relief without state-level complications. The patchwork creates a new layer of tax planning—MSOs will need state-by-state analysis to model net tax impact rather than assuming uniform relief nationwide.

Investor and M&A Implications

Rescheduling's tax windfall is already baked into MSO valuations, but the timing and mechanics remain the variable. Public MSOs have traded up 40-60% since the DEA's August 2024 rescheduling recommendation, reflecting market anticipation of 280E repeal. The $1 billion refund figure, however, is new information that could drive a second valuation leg higher, particularly for companies with the largest retroactive claims.

Private equity and strategic acquirers are watching the refund math closely. A target company with $100 million in pending 280E refunds becomes $100 million more attractive overnight once rescheduling finalizes. Expect M&A activity to spike in Q1 2027 as buyers move to capture tax assets before sellers can reinvest them.

What Happens If Rescheduling Stalls

The DEA's rescheduling rule has cleared internal review but faces potential legal challenges from prohibitionist groups and Schedule I advocates. If a federal court issues a stay or the rule is delayed past 2027, MSOs will continue operating under 280E for another tax cycle. The three-year refund window will start closing on 2023 returns.

Nobody can model the political variable: a 2028 administration change. A new DEA administrator could theoretically pause or reverse rescheduling, though unwinding a finalized rule is procedurally difficult. The safer bet for operators? Prepare amended returns now and file the moment rescheduling becomes effective, locking in refunds before any policy reversal can take hold.

For full background on this story, see the CannIntel topic hub on Cannabis Rescheduling and 280E Tax Relief.